For instance, studies have shown that WNT2, secreted by tumor-associated fibroblasts, drives tumor cell proliferation and invasion, particularly in WNT2-positive ESCC cases, which are associated with aggressive disease and lymph node metastasis [75]. Here, WNT2 is linked to metastatic malignant neoplasm in the lymph nodes.